Life Edit Therapeutics Email Format
Biotechnology ResearchNorth Carolina, United States11-50 Employees
Life Edit Therapeutics, based in Durham, North Carolina, focuses on advancing next-generation gene editing technologies and therapies. It has built a broad platform with a large and diverse collection of gene-editing components, enabling multiple editing approaches. The technology is designed to modify gene targets both in vivo and ex vivo, with the aim of addressing difficult genetic diseases. Positioned in the biotechnology research industry, the company serves researchers and industry partners pursuing transformative genetic medicines by providing access to its expansive platform to support discovery and development. In March 2026, Sartorius announced a partnership to test the Eveo platform, reflecting ongoing collaborations with ecosystem partners to expand its capabilities.